×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Black Diamond Therapeutics Inc. (BDTX) NASDAQ

$4.98 (0.34) (-6.39%)

Market Cap: $299.26M

As of 06/20/24 04:00 PM EDT. Market closed.

(BDTX)

Black Diamond Therapeutics Inc. (BDTX)
NASDAQ

$4.98
(0.34) (-6.39%)

Market Cap: $299.26M

As of 06/20/24 04:00 PM EDT. Market closed.

Add to Portfolio

black diamond therapeutics, inc., a precision oncology medicine company, discovers and develops small molecule, tumor-agnostic therapies. its lead product candidate is bdtx-189, an inhibitor of non-canonical and oncogenic mutations of erbb kinases epidermal growth factor receptor (egfr) and tyrosine-protein kinase. the company is also developing allosteric-egfr mutation inhibitors; and various ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
80
Address
.
PRICE CHART FOR BLACK DIAMOND THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.29
Previous Close
$5.32
Days Range
$4.94 - $5.37
52 week range
$1.62 - $7.66
Volume
629,944
Avg. Volume (30 days)
589,517
Market Cap
$299.26M
Dividend Yield
-
P/E
-
Shares Outstanding
56,252,794
Open
$5.29
Previous Close
$5.32
Days Range
$4.94 - $5.37
52 week range
$1.62 - $7.66
Volume
629,944
Avg. Volume (30 days)
589,517
Market Cap
$299.26M
Dividend Yield
-
P/E
-
Shares Outstanding
56,252,794
FINANCIAL STATEMENTS FOR BLACK DIAMOND THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BLACK DIAMOND THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Behbahani AliDirectorMar 15, 2024 Option Exercise$4.543,16614,37451,690Apr 03, 2024, 09:00 PM
DIXON WENDY LDirectorMar 15, 2024 Option Exercise$4.543,25314,76938,054Apr 03, 2024, 08:49 PM
Behbahani AliDirectorDec 15, 2023 Option Exercise$2.734,45512,16248,524Dec 15, 2023, 04:48 PM
DIXON WENDY LDirectorDec 15, 2023 Option Exercise$2.734,04311,03734,801Dec 15, 2023, 04:40 PM
BIOTECH GROWTH N V10% OwnerOct 17, 2023 Buy$2.34400,000934,0808,517,839Oct 19, 2023, 03:08 PM
Behbahani AliDirectorSep 15, 2023 Option Exercise$3.603,29911,87644,069Sep 18, 2023, 05:34 PM
Velleca Mark A.PRESIDENT & CEOSep 15, 2023 Option Exercise$3.605,20818,74946,522Sep 18, 2023, 05:26 PM
DIXON WENDY LDirectorSep 15, 2023 Option Exercise$3.602,98610,75030,758Sep 18, 2023, 05:25 PM
RA CAPITAL MANAGEMENT, L.P.DirectorJul 05, 2023 Buy$5.00935,8504,679,2503,213,828Jul 07, 2023, 04:30 PM
Behbahani AliDirectorJul 05, 2023 Buy$5.001,000,0005,000,0004,448,757Jul 06, 2023, 04:45 PM
BIOTECH GROWTH N V10% OwnerJun 30, 2023 Buy$5.001,000,0005,000,0008,117,839Jul 03, 2023, 03:36 PM
BIOTECH GROWTH N V10% OwnerJun 27, 2023 Buy$5.491,740,0009,555,0367,117,839Jun 29, 2023, 01:37 PM
Epstein David M.SEE REMARKSJun 27, 2023 Sale$6.7025,000167,500671,423Jun 28, 2023, 04:02 PM
Behbahani AliDirectorJun 16, 2023 Option Exercise$2.105,65511,87540,770Jun 16, 2023, 06:42 PM
DIXON WENDY LDirectorJun 16, 2023 Option Exercise$2.105,11910,75027,772Jun 16, 2023, 05:41 PM
Velleca Mark A.DirectorJun 16, 2023 Option Exercise$2.108,92918,75141,314Jun 16, 2023, 05:41 PM
Behbahani AliDirectorMar 16, 2023 Option Exercise$1.677,11111,87535,115Mar 20, 2023, 04:41 PM
DIXON WENDY LDirectorMar 16, 2023 Option Exercise$1.676,43710,75022,653Mar 20, 2023, 04:34 PM
Velleca Mark A.DirectorMar 16, 2023 Option Exercise$1.6711,22818,75132,385Mar 20, 2023, 04:33 PM
Ni FangSEE REMARKSDec 21, 2022 Buy$1.2920,00025,77089,026Dec 23, 2022, 04:23 PM
Ni FangSEE REMARKSDec 22, 2022 Buy$1.2836,36346,596125,389Dec 23, 2022, 04:23 PM
Behbahani AliDirectorDec 16, 2022 Option Exercise$1.507,91711,87628,004Dec 19, 2022, 09:27 PM
Velleca Mark A.DirectorDec 16, 2022 Option Exercise$1.508,42412,63621,157Dec 19, 2022, 09:16 PM
DIXON WENDY LDirectorDec 16, 2022 Option Exercise$1.507,16710,75116,216Dec 19, 2022, 09:15 PM
INGRAM ROBERT ALEXANDERFORMER DIRECTORDec 16, 2022 Option Exercise$1.509,37514,06342,854Dec 19, 2022, 09:14 PM
BIOTECH GROWTH N V10% OwnerOct 31, 2022 Buy$2.2599,801224,9125,377,839Nov 02, 2022, 03:10 PM
BIOTECH GROWTH N V10% OwnerOct 27, 2022 Buy$1.87191,678359,2245,105,064Oct 31, 2022, 03:20 PM
BIOTECH GROWTH N V10% OwnerOct 28, 2022 Buy$2.18172,974376,9625,278,038Oct 31, 2022, 03:20 PM
BIOTECH GROWTH N V10% OwnerOct 21, 2022 Buy$1.5187,850132,7504,913,386Oct 25, 2022, 04:24 PM
BIOTECH GROWTH N V10% OwnerOct 20, 2022 Buy$1.4253,73476,3454,825,536Oct 21, 2022, 03:06 PM
BIOTECH GROWTH N V10% OwnerOct 19, 2022 Buy$1.3277,689102,7754,771,802Oct 21, 2022, 03:06 PM
Behbahani AliDirectorSep 16, 2022 Option Exercise$2.624,53211,87420,087Sep 19, 2022, 06:39 PM
DIXON WENDY LDirectorSep 16, 2022 Option Exercise$2.624,10310,7509,049Sep 19, 2022, 05:10 PM
Velleca Mark A.DirectorSep 16, 2022 Option Exercise$2.624,29411,25012,733Sep 19, 2022, 05:09 PM
INGRAM ROBERT ALEXANDERDirectorSep 16, 2022 Option Exercise$2.626,58417,25033,479Sep 19, 2022, 05:08 PM
DIXON WENDY LDirectorJun 17, 2022 Option Exercise$2.034,94610,0404,946Jun 30, 2022, 04:07 PM
Ni FangSEE REMARKSJun 29, 2022 Buy$2.4425,00061,01869,026Jun 30, 2022, 04:05 PM
Behbahani AliDirectorJun 17, 2022 Option Exercise$2.035,85011,87515,555Jun 17, 2022, 04:35 PM
Velleca Mark A.DirectorJun 17, 2022 Option Exercise$2.035,54211,2508,439Jun 17, 2022, 04:27 PM
DIXON WENDY LDirectorJun 17, 2022 Option Exercise$2.034,0608,2424,060Jun 17, 2022, 04:26 PM
INGRAM ROBERT ALEXANDERDirectorJun 17, 2022 Option Exercise$2.038,49817,25126,895Jun 17, 2022, 04:25 PM
BIOTECH GROWTH N V10% OwnerApr 28, 2022 Buy$2.57255,711657,8684,694,113Apr 29, 2022, 10:50 AM
BIOTECH GROWTH N V10% OwnerApr 27, 2022 Buy$2.66150,000399,4804,438,402Apr 29, 2022, 10:50 AM
BIOTECH GROWTH N V10% OwnerApr 19, 2022 Buy$3.24150,000486,6454,288,402Apr 20, 2022, 12:56 PM
BIOTECH GROWTH N V10% OwnerApr 18, 2022 Buy$3.29150,000493,9354,138,402Apr 20, 2022, 12:56 PM
BIOTECH GROWTH N V10% OwnerApr 12, 2022 Buy$3.42150,000513,6003,885,846Apr 14, 2022, 12:09 PM
BIOTECH GROWTH N V10% OwnerApr 13, 2022 Buy$3.57102,556366,2173,988,402Apr 14, 2022, 12:09 PM
Behbahani AliDirectorMar 18, 2022 Option Exercise$3.024,34613,1259,705Mar 18, 2022, 04:15 PM
INGRAM ROBERT ALEXANDERDirectorMar 18, 2022 Option Exercise$3.025,79517,50118,397Mar 18, 2022, 04:05 PM
Velleca Mark A.DirectorMar 18, 2022 Option Exercise$3.022,8978,7492,897Mar 18, 2022, 04:05 PM
Behbahani AliDirectorDec 17, 2021 Option Exercise$5.312,47213,1265,359Dec 17, 2021, 04:50 PM
INGRAM ROBERT ALEXANDERDirectorDec 17, 2021 Option Exercise$5.313,29617,50212,602Dec 17, 2021, 04:12 PM
Behbahani AliDirectorSep 17, 2021 Option Exercise$9.901,32613,1272,887Sep 23, 2021, 05:43 PM
INGRAM ROBERT ALEXANDERDirectorSep 17, 2021 Option Exercise$9.901,86918,5039,306Sep 23, 2021, 05:33 PM
INGRAM ROBERT ALEXANDERDirectorJun 18, 2021 Option Exercise$12.951,25516,2527,437Jun 22, 2021, 06:13 PM
Hatzis-Schoch BrentSee RemarksMay 12, 2021 Option Exercise$3.204,07813,05012,478May 13, 2021, 04:53 PM
Hatzis-Schoch BrentSee RemarksMay 12, 2021 Sale$27.424,078111,80511,317May 13, 2021, 04:53 PM
Roberts Christopher D.Chief Scientific OfficerMay 03, 2021 Option Exercise$10.862,50027,1505,700May 05, 2021, 04:31 PM
Roberts Christopher D.Chief Scientific OfficerMay 03, 2021 Sale$26.642,50066,6023,200May 05, 2021, 04:31 PM
Hatzis-Schoch BrentSee RemarksApr 12, 2021 Option Exercise$3.204,07813,05012,478Apr 13, 2021, 08:45 PM
Hatzis-Schoch BrentSee RemarksApr 12, 2021 Sale$25.004,078101,9508,400Apr 13, 2021, 08:45 PM
Shah Rajeev M.DirectorApr 01, 2021 Option Exercise$24.26353,8148,583,5282,277,978Apr 05, 2021, 04:34 PM
Behbahani AliDirectorMar 18, 2021 Option Exercise$24.0154713,133547Mar 22, 2021, 08:33 PM
Shah Rajeev M.DirectorMar 18, 2021 Option Exercise$24.0144310,636443Mar 22, 2021, 08:25 PM
INGRAM ROBERT ALEXANDERDirectorMar 18, 2021 Option Exercise$24.0167716,2556,182Mar 22, 2021, 08:19 PM
Hatzis-Schoch BrentSee RemarksMar 12, 2021 Option Exercise$3.204,07813,05012,478Mar 16, 2021, 04:56 PM
Hatzis-Schoch BrentSee RemarksMar 12, 2021 Sale$26.364,078107,4938,400Mar 16, 2021, 04:56 PM
Roberts Christopher D.Chief Scientific OfficerMar 03, 2021 Option Exercise$10.862,50027,1505,700Mar 04, 2021, 05:52 PM
Roberts Christopher D.Chief Scientific OfficerMar 03, 2021 Sale$26.102,50065,2624,084Mar 04, 2021, 05:52 PM
Hatzis-Schoch BrentSee RemarksFeb 12, 2021 Option Exercise$3.204,07813,05012,478Feb 12, 2021, 09:24 PM
Hatzis-Schoch BrentSee RemarksFeb 12, 2021 Sale$27.234,078111,0258,707Feb 12, 2021, 09:24 PM
Roberts Christopher D.Chief Scientific OfficerFeb 03, 2021 Option Exercise$10.862,50027,1505,700Feb 04, 2021, 05:47 PM
Roberts Christopher D.Chief Scientific OfficerFeb 03, 2021 Sale$25.352,50063,3753,200Feb 04, 2021, 05:47 PM
Hatzis-Schoch BrentSee RemarksJan 12, 2021 Option Exercise$8.1611,57894,50019,978Jan 14, 2021, 08:57 PM
Hatzis-Schoch BrentSee RemarksJan 12, 2021 Sale$34.0311,578394,04117,930Jan 14, 2021, 08:57 PM
Leggett ThomasChief Financial OfficerJan 08, 2021 Option Exercise$10.863,00032,5803,000Jan 11, 2021, 05:59 PM
Leggett ThomasChief Financial OfficerJan 08, 2021 Sale$33.943,000101,8200Jan 11, 2021, 05:59 PM
Roberts Christopher D.Chief Scientific OfficerJan 04, 2021 Option Exercise$10.862,50027,1505,700Jan 06, 2021, 06:27 PM
Roberts Christopher D.Chief Scientific OfficerJan 04, 2021 Sale$31.412,50078,5253,737Jan 06, 2021, 06:27 PM
Epstein David M.See RemarksJan 04, 2021 Option Exercise$6.423,00019,260708,423Jan 06, 2021, 06:21 PM
Epstein David M.See RemarksJan 04, 2021 Sale$31.1312,000373,505698,438Jan 06, 2021, 06:21 PM
Hatzis-Schoch BrentSee RemarksDec 28, 2020 Option Exercise$3.205,40017,2808,400Dec 29, 2020, 04:46 PM
INGRAM ROBERT ALEXANDERDirectorDec 15, 2020 Option Exercise$34.2950517,3165,505Dec 16, 2020, 07:42 PM
Roberts Christopher D.Chief Scientific OfficerDec 15, 2020 Option Exercise$10.863,20034,7523,200Dec 16, 2020, 07:42 PM
Hatzis-Schoch BrentSee RemarksDec 14, 2020 Option Exercise$3.204,07813,0507,078Dec 16, 2020, 07:41 PM
Hatzis-Schoch BrentSee RemarksDec 14, 2020 Sale$34.954,078142,5223,000Dec 16, 2020, 07:41 PM
Epstein David M.See RemarksDec 15, 2020 Option Exercise$6.422,50016,050705,423Dec 16, 2020, 07:39 PM
Leggett ThomasChief Financial OfficerDec 08, 2020 Option Exercise$10.863,00032,5803,000Dec 10, 2020, 04:16 PM
Leggett ThomasChief Financial OfficerDec 08, 2020 Sale$33.783,000101,3271,941Dec 10, 2020, 04:16 PM
Roberts Christopher D.Chief Scientific OfficerDec 03, 2020 Option Exercise$10.862,50027,1502,500Dec 04, 2020, 04:34 PM
Roberts Christopher D.Chief Scientific OfficerDec 03, 2020 Sale$32.422,50081,0550Dec 04, 2020, 04:34 PM
Epstein David M.See RemarksDec 01, 2020 Option Exercise$6.423,00019,260714,923Dec 03, 2020, 04:17 PM
Epstein David M.See RemarksDec 01, 2020 Sale$32.7112,000392,574704,000Dec 03, 2020, 04:17 PM
Bolzon Bradley J PhDDirectorNov 30, 2020 Sale$33.1510,393344,513874,299Dec 01, 2020, 07:13 PM
Versant Venture Capital VI, L.P.10% OwnerNov 30, 2020 Sale$33.1510,393344,513874,299Dec 01, 2020, 07:13 PM
Versant Venture Capital VI, L.P.10% OwnerNov 19, 2020 Sale$33.01114,8543,791,3304,818,600Nov 23, 2020, 04:41 PM
Versant Venture Capital VI, L.P.10% OwnerNov 19, 2020 Sale$33.0115,163500,531968,954Nov 23, 2020, 04:41 PM
Bolzon Bradley J PhDDirectorNov 19, 2020 Sale$33.01130,0174,291,8614,818,600Nov 23, 2020, 04:39 PM
Bolzon Bradley J PhDDirectorNov 18, 2020 Sale$33.0953617,7384,933,454Nov 19, 2020, 09:19 PM
Bolzon Bradley J PhDDirectorNov 17, 2020 Sale$33.054,194138,6114,933,927Nov 19, 2020, 09:19 PM
Versant Venture Capital VI, L.P.10% OwnerNov 18, 2020 Sale$33.0947315,6534,933,454Nov 19, 2020, 09:19 PM
Versant Venture Capital VI, L.P.10% OwnerNov 18, 2020 Sale$33.09632,085984,117Nov 19, 2020, 09:19 PM
Versant Venture Capital VI, L.P.10% OwnerNov 17, 2020 Sale$33.053,705122,4504,933,927Nov 19, 2020, 09:19 PM
Versant Venture Capital VI, L.P.10% OwnerNov 17, 2020 Sale$33.0548916,161984,180Nov 19, 2020, 09:19 PM
Versant Venture Capital VI, L.P.10% OwnerNov 16, 2020 Sale$33.011775,8434,937,632Nov 17, 2020, 07:33 PM
Versant Venture Capital VI, L.P.10% OwnerNov 16, 2020 Sale$33.0123759984,669Nov 17, 2020, 07:33 PM
Versant Venture Capital VI, L.P.10% OwnerNov 13, 2020 Sale$33.773,975134,2534,939,311Nov 17, 2020, 07:33 PM
Versant Venture Capital VI, L.P.10% OwnerNov 13, 2020 Sale$33.7752517,731984,890Nov 17, 2020, 07:33 PM
Bolzon Bradley J PhDDirectorNov 16, 2020 Sale$33.012006,6034,937,632Nov 17, 2020, 07:28 PM
Bolzon Bradley J PhDDirectorNov 13, 2020 Sale$33.774,500151,9844,939,311Nov 17, 2020, 07:28 PM
Versant Venture Capital VI, L.P.10% OwnerNov 12, 2020 Sale$34.151,81962,116986,512Nov 13, 2020, 07:47 PM
Versant Venture Capital VI, L.P.10% OwnerNov 12, 2020 Sale$34.1513,779470,5264,951,587Nov 13, 2020, 07:47 PM
Bolzon Bradley J PhDDirectorNov 12, 2020 Sale$34.1515,598532,6424,951,587Nov 13, 2020, 07:46 PM
Roberts Christopher D.Chief Scientific OfficerNov 11, 2020 Option Exercise$10.865,00054,3005,000Nov 13, 2020, 04:26 PM
Roberts Christopher D.Chief Scientific OfficerNov 11, 2020 Sale$34.905,000174,5000Nov 13, 2020, 04:26 PM
Hatzis-Schoch BrentSee RemarksNov 12, 2020 Option Exercise$3.204,07813,0507,078Nov 13, 2020, 04:25 PM
Hatzis-Schoch BrentSee RemarksNov 12, 2020 Sale$33.994,078138,6075,511Nov 13, 2020, 04:25 PM
Versant Venture Capital VI, L.P.10% OwnerNov 11, 2020 Sale$34.7311,146387,1275,655,404Nov 12, 2020, 05:41 PM
Versant Venture Capital VI, L.P.10% OwnerNov 11, 2020 Sale$34.731,47151,091988,227Nov 12, 2020, 05:41 PM
Versant Venture Capital VI, L.P.10% OwnerNov 10, 2020 Sale$33.8323,821805,7555,669,956Nov 12, 2020, 05:41 PM
Versant Venture Capital VI, L.P.10% OwnerNov 10, 2020 Sale$33.833,145106,381990,149Nov 12, 2020, 05:41 PM
Bolzon Bradley J PhDDirectorNov 11, 2020 Sale$34.7312,617438,2175,655,404Nov 12, 2020, 05:38 PM
Bolzon Bradley J PhDDirectorNov 10, 2020 Sale$33.8326,966912,1365,669,956Nov 12, 2020, 05:38 PM
Leggett ThomasChief Financial OfficerNov 09, 2020 Option Exercise$10.863,00032,5803,000Nov 12, 2020, 05:00 PM
Leggett ThomasChief Financial OfficerNov 09, 2020 Sale$32.963,00098,8920Nov 12, 2020, 05:00 PM
Versant Venture Capital VI, L.P.10% OwnerNov 06, 2020 Sale$33.1336211,993992,387Nov 10, 2020, 07:24 PM
Versant Venture Capital VI, L.P.10% OwnerNov 09, 2020 Sale$33.065,565183,9545,681,344Nov 10, 2020, 07:24 PM
Versant Venture Capital VI, L.P.10% OwnerNov 09, 2020 Sale$33.0673524,296991,652Nov 10, 2020, 07:24 PM
Versant Venture Capital VI, L.P.10% OwnerNov 06, 2020 Sale$33.132,73890,7065,686,909Nov 10, 2020, 07:24 PM
Bolzon Bradley J PhDDirectorNov 09, 2020 Sale$33.066,300208,2505,681,344Nov 10, 2020, 07:24 PM
Bolzon Bradley J PhDDirectorNov 06, 2020 Sale$33.133,100102,6985,686,909Nov 10, 2020, 07:24 PM
Bolzon Bradley J PhDDirectorNov 05, 2020 Sale$33.158,848293,2875,689,647Nov 06, 2020, 04:49 PM
Bolzon Bradley J PhDDirectorNov 04, 2020 Sale$33.142,50082,8395,697,463Nov 06, 2020, 04:49 PM
Versant Venture Capital VI, L.P.10% OwnerNov 04, 2020 Sale$33.142929,676993,781Nov 06, 2020, 04:44 PM
Versant Venture Capital VI, L.P.10% OwnerNov 05, 2020 Sale$33.157,816259,0795,689,647Nov 06, 2020, 04:44 PM
Versant Venture Capital VI, L.P.10% OwnerNov 05, 2020 Sale$33.151,03234,208992,749Nov 06, 2020, 04:44 PM
Versant Venture Capital VI, L.P.10% OwnerNov 04, 2020 Sale$33.142,20873,1645,697,463Nov 06, 2020, 04:44 PM
Roberts Christopher D.Chief Scientific OfficerNov 03, 2020 Option Exercise$10.862,50027,1502,500Nov 04, 2020, 08:37 PM
Roberts Christopher D.Chief Scientific OfficerNov 03, 2020 Sale$31.952,50079,8730Nov 04, 2020, 08:37 PM
Epstein David M.See RemarksNov 02, 2020 Option Exercise$6.423,00019,260723,923Nov 03, 2020, 07:56 PM
Epstein David M.See RemarksNov 02, 2020 Sale$31.1412,000373,656712,006Nov 03, 2020, 07:56 PM
Versant Venture Capital VI, L.P.10% OwnerOct 26, 2020 Sale$33.307,158238,3945,700,378Oct 28, 2020, 05:58 PM
Versant Venture Capital VI, L.P.10% OwnerOct 26, 2020 Sale$33.3094531,473994,166Oct 28, 2020, 05:58 PM
Versant Venture Capital VI, L.P.10% OwnerOct 27, 2020 Sale$33.0370723,3545,699,671Oct 28, 2020, 05:58 PM
Versant Venture Capital VI, L.P.10% OwnerOct 27, 2020 Sale$33.03933,072994,073Oct 28, 2020, 05:58 PM
Bolzon Bradley J PhDDirectorOct 27, 2020 Sale$33.0380026,4265,699,671Oct 28, 2020, 05:51 PM
Bolzon Bradley J PhDDirectorOct 26, 2020 Sale$33.308,103269,8675,700,378Oct 28, 2020, 05:51 PM
Versant Venture Capital VI, L.P.10% OwnerOct 16, 2020 Sale$33.577,697258,4105,711,275Oct 20, 2020, 08:09 PM
Versant Venture Capital VI, L.P.10% OwnerOct 16, 2020 Sale$33.571,01634,110995,605Oct 20, 2020, 08:09 PM
Versant Venture Capital VI, L.P.10% OwnerOct 15, 2020 Sale$33.032,47381,6945,718,972Oct 20, 2020, 08:09 PM
Versant Venture Capital VI, L.P.10% OwnerOct 15, 2020 Sale$33.0332710,802996,621Oct 20, 2020, 08:09 PM
Versant Venture Capital VI, L.P.10% OwnerOct 19, 2020 Sale$33.433,739124,9985,707,536Oct 20, 2020, 08:09 PM
Versant Venture Capital VI, L.P.10% OwnerOct 19, 2020 Sale$33.4349416,515995,111Oct 20, 2020, 08:09 PM
Bolzon Bradley J PhDDirectorOct 19, 2020 Sale$33.434,233141,5135,707,536Oct 20, 2020, 08:03 PM
Bolzon Bradley J PhDDirectorOct 16, 2020 Sale$33.578,713292,5205,711,275Oct 20, 2020, 08:03 PM
Bolzon Bradley J PhDDirectorOct 15, 2020 Sale$33.032,80092,4965,718,972Oct 20, 2020, 08:03 PM
Bolzon Bradley J PhDDirectorOct 14, 2020 Sale$33.095,501182,0315,721,445Oct 15, 2020, 07:26 PM
Bolzon Bradley J PhDDirectorOct 13, 2020 Sale$33.3911,739391,9845,726,304Oct 15, 2020, 07:26 PM
Versant Venture Capital VI, L.P.10% OwnerOct 14, 2020 Sale$33.094,859160,7875,721,445Oct 15, 2020, 07:22 PM
Versant Venture Capital VI, L.P.10% OwnerOct 14, 2020 Sale$33.0964221,244996,948Oct 15, 2020, 07:22 PM
Versant Venture Capital VI, L.P.10% OwnerOct 13, 2020 Sale$33.3910,370346,2715,726,304Oct 15, 2020, 07:22 PM
Versant Venture Capital VI, L.P.10% OwnerOct 13, 2020 Sale$33.391,36945,713997,590Oct 15, 2020, 07:22 PM
Hatzis-Schoch BrentSee RemarksOct 12, 2020 Option Exercise$3.204,07813,0507,078Oct 14, 2020, 04:32 PM
Hatzis-Schoch BrentSee RemarksOct 12, 2020 Sale$32.704,078133,3313,295Oct 14, 2020, 04:32 PM
Bolzon Bradley J PhDDirectorOct 12, 2020 Sale$33.1140013,2435,736,674Oct 13, 2020, 07:48 PM
Bolzon Bradley J PhDDirectorOct 09, 2020 Sale$33.673,800127,9335,737,027Oct 13, 2020, 07:48 PM
Bolzon Bradley J PhDDirectorOct 08, 2020 Sale$33.4718,425616,7485,748,886Oct 13, 2020, 07:48 PM
Versant Venture Capital VI, L.P.10% OwnerOct 09, 2020 Sale$33.673,357113,0185,737,027Oct 13, 2020, 07:41 PM
Versant Venture Capital VI, L.P.10% OwnerOct 09, 2020 Sale$33.6744314,914999,006Oct 13, 2020, 07:41 PM
Versant Venture Capital VI, L.P.10% OwnerOct 08, 2020 Sale$33.4716,276544,8145,748,886Oct 13, 2020, 07:41 PM
Versant Venture Capital VI, L.P.10% OwnerOct 08, 2020 Sale$33.472,14971,9341,000,571Oct 13, 2020, 07:41 PM
Versant Venture Capital VI, L.P.10% OwnerOct 12, 2020 Sale$33.1135311,6875,736,674Oct 13, 2020, 07:41 PM
Versant Venture Capital VI, L.P.10% OwnerOct 12, 2020 Sale$33.11471,556998,959Oct 13, 2020, 07:41 PM
Leggett ThomasChief Financial OfficerOct 08, 2020 Option Exercise$10.863,00032,5803,000Oct 09, 2020, 04:12 PM
Leggett ThomasChief Financial OfficerOct 08, 2020 Sale$33.533,000100,5760Oct 09, 2020, 04:12 PM
Bolzon Bradley J PhDDirectorOct 07, 2020 Sale$33.5627,836934,0795,756,660Oct 08, 2020, 07:14 PM
Bolzon Bradley J PhDDirectorOct 06, 2020 Sale$33.2618,090601,6535,781,250Oct 08, 2020, 07:14 PM
Versant Venture Capital VI, L.P.10% OwnerOct 07, 2020 Sale$33.5624,590825,1545,756,660Oct 08, 2020, 07:14 PM
Versant Venture Capital VI, L.P.10% OwnerOct 07, 2020 Sale$33.563,246108,9241,041,206Oct 08, 2020, 07:14 PM
Versant Venture Capital VI, L.P.10% OwnerOct 06, 2020 Sale$33.2615,980531,4775,781,250Oct 08, 2020, 07:14 PM
Versant Venture Capital VI, L.P.10% OwnerOct 06, 2020 Sale$33.262,11070,1761,044,452Oct 08, 2020, 07:14 PM
Roberts Christopher D.Chief Scientific OfficerOct 05, 2020 Option Exercise$10.862,50027,1502,500Oct 07, 2020, 04:27 PM
Roberts Christopher D.Chief Scientific OfficerOct 05, 2020 Sale$31.282,50078,188227Oct 07, 2020, 04:27 PM
Epstein David M.See RemarksOct 01, 2020 Option Exercise$6.423,00019,260732,923Oct 02, 2020, 05:07 PM
Epstein David M.See RemarksOct 01, 2020 Sale$30.3312,000363,962720,923Oct 02, 2020, 05:07 PM
INGRAM ROBERT ALEXANDERDirectorSep 30, 2020 Buy$30.465,000152,2855,000Oct 01, 2020, 04:06 PM
Hatzis-Schoch BrentSee RemarksSep 14, 2020 Option Exercise$3.204,07813,0507,078Sep 16, 2020, 06:11 PM
Hatzis-Schoch BrentSee RemarksSep 14, 2020 Sale$31.044,078126,5834,393Sep 16, 2020, 06:11 PM
Leggett ThomasChief Financial OfficerSep 14, 2020 Option Exercise$10.863,00032,5803,000Sep 16, 2020, 06:09 PM
Leggett ThomasChief Financial OfficerSep 14, 2020 Sale$31.003,00093,0000Sep 16, 2020, 06:09 PM
Roberts Christopher D.Chief Scientific OfficerSep 03, 2020 Option Exercise$10.862,50027,1502,500Sep 04, 2020, 05:27 PM
Roberts Christopher D.Chief Scientific OfficerSep 03, 2020 Sale$29.592,50073,9872,358Sep 04, 2020, 05:27 PM
Versant Venture Capital VI, L.P.10% OwnerAug 10, 2020 Sale$33.045,492181,4466,803,922Aug 12, 2020, 07:57 PM
Versant Venture Capital VI, L.P.10% OwnerAug 10, 2020 Sale$33.0472523,9531,126,661Aug 12, 2020, 07:57 PM
Versant Venture Capital VI, L.P.10% OwnerAug 11, 2020 Sale$33.086,692221,3806,797,230Aug 12, 2020, 07:57 PM
Versant Venture Capital VI, L.P.10% OwnerAug 11, 2020 Sale$33.0888329,2111,125,778Aug 12, 2020, 07:57 PM
Bolzon Bradley J PhDDirectorAug 11, 2020 Sale$33.087,575250,5916,797,230Aug 12, 2020, 07:46 PM
Bolzon Bradley J PhDDirectorAug 10, 2020 Sale$33.046,217205,3986,803,922Aug 12, 2020, 07:46 PM
Versant Venture Capital VI, L.P.10% OwnerFeb 03, 2020 Buy$19.00396,0827,525,5586,809,414Feb 05, 2020, 06:02 PM
Versant Venture Capital VI, L.P.10% OwnerFeb 03, 2020 Buy$19.00498,6549,474,4262,209,592Feb 05, 2020, 06:02 PM
Bolzon Bradley J PhDDirectorFeb 03, 2020 Buy$19.00894,73616,999,9846,809,414Feb 05, 2020, 05:59 PM
Shah Rajeev M.DirectorFeb 03, 2020 Buy$19.001,000,00019,000,0001,924,164Feb 05, 2020, 05:58 PM
Hatzis-Schoch BrentSee RemarksFeb 03, 2020 Buy$19.003,00057,0003,000Feb 05, 2020, 05:55 PM
Behbahani AliDirectorFeb 03, 2020 Buy$19.00800,00015,200,0003,448,757Feb 05, 2020, 05:55 PM
Flynn James E10% OwnerFeb 03, 2020 Buy$19.00400,0007,600,000778,790Feb 03, 2020, 01:25 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Behbahani AliDirector03/15/202414,374
DIXON WENDY LDirector03/15/202414,769
Behbahani AliDirector12/15/202312,162
DIXON WENDY LDirector12/15/202311,037
BIOTECH GROWTH N V10% Owner10/17/2023934,080
Behbahani AliDirector09/15/202311,876
Velleca Mark A.PRESIDENT & CEO09/15/202318,749
DIXON WENDY LDirector09/15/202310,750
RA CAPITAL MANAGEMENT, L.P.Director07/05/20234,679,250
Behbahani AliDirector07/05/20235,000,000
BIOTECH GROWTH N V10% Owner06/30/20235,000,000
BIOTECH GROWTH N V10% Owner06/27/20239,555,036
Epstein David M.SEE REMARKS06/27/2023167,500
Behbahani AliDirector06/16/202311,875
DIXON WENDY LDirector06/16/202310,750
Velleca Mark A.Director06/16/202318,751
Behbahani AliDirector03/16/202311,875
DIXON WENDY LDirector03/16/202310,750
Velleca Mark A.Director03/16/202318,751
Ni FangSEE REMARKS12/21/202225,770
Ni FangSEE REMARKS12/22/202246,596
Behbahani AliDirector12/16/202211,876
Velleca Mark A.Director12/16/202212,636
DIXON WENDY LDirector12/16/202210,751
INGRAM ROBERT ALEXANDERFORMER DIRECTOR12/16/202214,063
BIOTECH GROWTH N V10% Owner10/31/2022224,912
BIOTECH GROWTH N V10% Owner10/27/2022359,224
BIOTECH GROWTH N V10% Owner10/28/2022376,962
BIOTECH GROWTH N V10% Owner10/21/2022132,750
BIOTECH GROWTH N V10% Owner10/20/202276,345
BIOTECH GROWTH N V10% Owner10/19/2022102,775
Behbahani AliDirector09/16/202211,874
DIXON WENDY LDirector09/16/202210,750
Velleca Mark A.Director09/16/202211,250
INGRAM ROBERT ALEXANDERDirector09/16/202217,250
DIXON WENDY LDirector06/17/202210,040
Ni FangSEE REMARKS06/29/202261,018
Behbahani AliDirector06/17/202211,875
Velleca Mark A.Director06/17/202211,250
DIXON WENDY LDirector06/17/20228,242
INGRAM ROBERT ALEXANDERDirector06/17/202217,251
BIOTECH GROWTH N V10% Owner04/28/2022657,868
BIOTECH GROWTH N V10% Owner04/27/2022399,480
BIOTECH GROWTH N V10% Owner04/19/2022486,645
BIOTECH GROWTH N V10% Owner04/18/2022493,935
BIOTECH GROWTH N V10% Owner04/12/2022513,600
BIOTECH GROWTH N V10% Owner04/13/2022366,217
Behbahani AliDirector03/18/202213,125
INGRAM ROBERT ALEXANDERDirector03/18/202217,501
Velleca Mark A.Director03/18/20228,749
Behbahani AliDirector12/17/202113,126
INGRAM ROBERT ALEXANDERDirector12/17/202117,502
Behbahani AliDirector09/17/202113,127
INGRAM ROBERT ALEXANDERDirector09/17/202118,503
INGRAM ROBERT ALEXANDERDirector06/18/202116,252
Hatzis-Schoch BrentSee Remarks05/12/202113,050
Hatzis-Schoch BrentSee Remarks05/12/2021111,805
Roberts Christopher D.Chief Scientific Officer05/03/202127,150
Roberts Christopher D.Chief Scientific Officer05/03/202166,602
Hatzis-Schoch BrentSee Remarks04/12/202113,050
Hatzis-Schoch BrentSee Remarks04/12/2021101,950
Shah Rajeev M.Director04/01/20218,583,528
Behbahani AliDirector03/18/202113,133
Shah Rajeev M.Director03/18/202110,636
INGRAM ROBERT ALEXANDERDirector03/18/202116,255
Hatzis-Schoch BrentSee Remarks03/12/202113,050
Hatzis-Schoch BrentSee Remarks03/12/2021107,493
Roberts Christopher D.Chief Scientific Officer03/03/202127,150
Roberts Christopher D.Chief Scientific Officer03/03/202165,262
Hatzis-Schoch BrentSee Remarks02/12/202113,050
Hatzis-Schoch BrentSee Remarks02/12/2021111,025
Roberts Christopher D.Chief Scientific Officer02/03/202127,150
Roberts Christopher D.Chief Scientific Officer02/03/202163,375
Hatzis-Schoch BrentSee Remarks01/12/202194,500
Hatzis-Schoch BrentSee Remarks01/12/2021394,041
Leggett ThomasChief Financial Officer01/08/202132,580
Leggett ThomasChief Financial Officer01/08/2021101,820
Roberts Christopher D.Chief Scientific Officer01/04/202127,150
Roberts Christopher D.Chief Scientific Officer01/04/202178,525
Epstein David M.See Remarks01/04/202119,260
Epstein David M.See Remarks01/04/2021373,505
Hatzis-Schoch BrentSee Remarks12/28/202017,280
INGRAM ROBERT ALEXANDERDirector12/15/202017,316
Roberts Christopher D.Chief Scientific Officer12/15/202034,752
Hatzis-Schoch BrentSee Remarks12/14/202013,050
Hatzis-Schoch BrentSee Remarks12/14/2020142,522
Epstein David M.See Remarks12/15/202016,050
Leggett ThomasChief Financial Officer12/08/202032,580
Leggett ThomasChief Financial Officer12/08/2020101,327
Roberts Christopher D.Chief Scientific Officer12/03/202027,150
Roberts Christopher D.Chief Scientific Officer12/03/202081,055
Epstein David M.See Remarks12/01/202019,260
Epstein David M.See Remarks12/01/2020392,574
Bolzon Bradley J PhDDirector11/30/2020344,513
Versant Venture Capital VI, L.P.10% Owner11/30/2020344,513
Versant Venture Capital VI, L.P.10% Owner11/19/20203,791,330
Versant Venture Capital VI, L.P.10% Owner11/19/2020500,531
Bolzon Bradley J PhDDirector11/19/20204,291,861
Bolzon Bradley J PhDDirector11/18/202017,738
Bolzon Bradley J PhDDirector11/17/2020138,611
Versant Venture Capital VI, L.P.10% Owner11/18/202015,653
Versant Venture Capital VI, L.P.10% Owner11/18/20202,085
Versant Venture Capital VI, L.P.10% Owner11/17/2020122,450
Versant Venture Capital VI, L.P.10% Owner11/17/202016,161
Versant Venture Capital VI, L.P.10% Owner11/16/20205,843
Versant Venture Capital VI, L.P.10% Owner11/16/2020759
Versant Venture Capital VI, L.P.10% Owner11/13/2020134,253
Versant Venture Capital VI, L.P.10% Owner11/13/202017,731
Bolzon Bradley J PhDDirector11/16/20206,603
Bolzon Bradley J PhDDirector11/13/2020151,984
Versant Venture Capital VI, L.P.10% Owner11/12/202062,116
Versant Venture Capital VI, L.P.10% Owner11/12/2020470,526
Bolzon Bradley J PhDDirector11/12/2020532,642
Roberts Christopher D.Chief Scientific Officer11/11/202054,300
Roberts Christopher D.Chief Scientific Officer11/11/2020174,500
Hatzis-Schoch BrentSee Remarks11/12/202013,050
Hatzis-Schoch BrentSee Remarks11/12/2020138,607
Versant Venture Capital VI, L.P.10% Owner11/11/2020387,127
Versant Venture Capital VI, L.P.10% Owner11/11/202051,091
Versant Venture Capital VI, L.P.10% Owner11/10/2020805,755
Versant Venture Capital VI, L.P.10% Owner11/10/2020106,381
Bolzon Bradley J PhDDirector11/11/2020438,217
Bolzon Bradley J PhDDirector11/10/2020912,136
Leggett ThomasChief Financial Officer11/09/202032,580
Leggett ThomasChief Financial Officer11/09/202098,892
Versant Venture Capital VI, L.P.10% Owner11/06/202011,993
Versant Venture Capital VI, L.P.10% Owner11/09/2020183,954
Versant Venture Capital VI, L.P.10% Owner11/09/202024,296
Versant Venture Capital VI, L.P.10% Owner11/06/202090,706
Bolzon Bradley J PhDDirector11/09/2020208,250
Bolzon Bradley J PhDDirector11/06/2020102,698
Bolzon Bradley J PhDDirector11/05/2020293,287
Bolzon Bradley J PhDDirector11/04/202082,839
Versant Venture Capital VI, L.P.10% Owner11/04/20209,676
Versant Venture Capital VI, L.P.10% Owner11/05/2020259,079
Versant Venture Capital VI, L.P.10% Owner11/05/202034,208
Versant Venture Capital VI, L.P.10% Owner11/04/202073,164
Roberts Christopher D.Chief Scientific Officer11/03/202027,150
Roberts Christopher D.Chief Scientific Officer11/03/202079,873
Epstein David M.See Remarks11/02/202019,260
Epstein David M.See Remarks11/02/2020373,656
Versant Venture Capital VI, L.P.10% Owner10/26/2020238,394
Versant Venture Capital VI, L.P.10% Owner10/26/202031,473
Versant Venture Capital VI, L.P.10% Owner10/27/202023,354
Versant Venture Capital VI, L.P.10% Owner10/27/20203,072
Bolzon Bradley J PhDDirector10/27/202026,426
Bolzon Bradley J PhDDirector10/26/2020269,867
Versant Venture Capital VI, L.P.10% Owner10/16/2020258,410
Versant Venture Capital VI, L.P.10% Owner10/16/202034,110
Versant Venture Capital VI, L.P.10% Owner10/15/202081,694
Versant Venture Capital VI, L.P.10% Owner10/15/202010,802
Versant Venture Capital VI, L.P.10% Owner10/19/2020124,998
Versant Venture Capital VI, L.P.10% Owner10/19/202016,515
Bolzon Bradley J PhDDirector10/19/2020141,513
Bolzon Bradley J PhDDirector10/16/2020292,520
Bolzon Bradley J PhDDirector10/15/202092,496
Bolzon Bradley J PhDDirector10/14/2020182,031
Bolzon Bradley J PhDDirector10/13/2020391,984
Versant Venture Capital VI, L.P.10% Owner10/14/2020160,787
Versant Venture Capital VI, L.P.10% Owner10/14/202021,244
Versant Venture Capital VI, L.P.10% Owner10/13/2020346,271
Versant Venture Capital VI, L.P.10% Owner10/13/202045,713
Hatzis-Schoch BrentSee Remarks10/12/202013,050
Hatzis-Schoch BrentSee Remarks10/12/2020133,331
Bolzon Bradley J PhDDirector10/12/202013,243
Bolzon Bradley J PhDDirector10/09/2020127,933
Bolzon Bradley J PhDDirector10/08/2020616,748
Versant Venture Capital VI, L.P.10% Owner10/09/2020113,018
Versant Venture Capital VI, L.P.10% Owner10/09/202014,914
Versant Venture Capital VI, L.P.10% Owner10/08/2020544,814
Versant Venture Capital VI, L.P.10% Owner10/08/202071,934
Versant Venture Capital VI, L.P.10% Owner10/12/202011,687
Versant Venture Capital VI, L.P.10% Owner10/12/20201,556
Leggett ThomasChief Financial Officer10/08/202032,580
Leggett ThomasChief Financial Officer10/08/2020100,576
Bolzon Bradley J PhDDirector10/07/2020934,079
Bolzon Bradley J PhDDirector10/06/2020601,653
Versant Venture Capital VI, L.P.10% Owner10/07/2020825,154
Versant Venture Capital VI, L.P.10% Owner10/07/2020108,924
Versant Venture Capital VI, L.P.10% Owner10/06/2020531,477
Versant Venture Capital VI, L.P.10% Owner10/06/202070,176
Roberts Christopher D.Chief Scientific Officer10/05/202027,150
Roberts Christopher D.Chief Scientific Officer10/05/202078,188
Epstein David M.See Remarks10/01/202019,260
Epstein David M.See Remarks10/01/2020363,962
INGRAM ROBERT ALEXANDERDirector09/30/2020152,285
Hatzis-Schoch BrentSee Remarks09/14/202013,050
Hatzis-Schoch BrentSee Remarks09/14/2020126,583
Leggett ThomasChief Financial Officer09/14/202032,580
Leggett ThomasChief Financial Officer09/14/202093,000
Roberts Christopher D.Chief Scientific Officer09/03/202027,150
Roberts Christopher D.Chief Scientific Officer09/03/202073,987
Versant Venture Capital VI, L.P.10% Owner08/10/2020181,446
Versant Venture Capital VI, L.P.10% Owner08/10/202023,953
Versant Venture Capital VI, L.P.10% Owner08/11/2020221,380
Versant Venture Capital VI, L.P.10% Owner08/11/202029,211
Bolzon Bradley J PhDDirector08/11/2020250,591
Bolzon Bradley J PhDDirector08/10/2020205,398
Versant Venture Capital VI, L.P.10% Owner02/03/20207,525,558
Versant Venture Capital VI, L.P.10% Owner02/03/20209,474,426
Bolzon Bradley J PhDDirector02/03/202016,999,984
Shah Rajeev M.Director02/03/202019,000,000
Hatzis-Schoch BrentSee Remarks02/03/202057,000
Behbahani AliDirector02/03/202015,200,000
Flynn James E10% Owner02/03/20207,600,000
Load More Insider Transactions
FUNDS WITH A POSITION IN BLACK DIAMOND THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RA CAPITAL MANAGEMENT, L.P.2,788,0280.26%-20.92%Other
BLACKROCK INC.1,380,5220.00016%2.26%Other
DRIEHAUS CAPITAL MANAGEMENT LLC605,9010.03%-13.07%Growth
CANDRIAM S.C.A.540,0090.01%ExitedOther
RENAISSANCE TECHNOLOGIES LLC212,6000.00169%-52.8%Other
GEODE CAPITAL MANAGEMENT, LLC382,6130.00018%9.18%Other
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC)257,0000.09%NewValue
BALYASNY ASSET MANAGEMENT L.P.34,9210.00031%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR BLACK DIAMOND THERAPEUTICS INC
STOCK BUYBACKS FOR BLACK DIAMOND THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
0.18%
1Q
03/31/2024
09/30/2023
1.70%
2Q
03/31/2024
03/31/2023
42.00%
4Q
03/31/2024
12/31/2022
42.37%
5Q
03/31/2024
09/30/2022
42.54%
6Q
03/31/2024
06/30/2022
42.75%
7Q
03/31/2024
03/31/2022
42.84%
8Q
03/31/2024
12/31/2021
43.00%
9Q
03/31/2024
09/30/2021
43.04%
10Q
03/31/2024
06/30/2021
43.19%
11Q
03/31/2024
03/31/2021
43.42%
12Q
03/31/2024
12/31/2020
43.73%
13Q
03/31/2024
09/30/2020
44.20%
14Q
03/31/2024
06/30/2020
44.27%
15Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
0.18%
1Q
09/30/2023
1.70%
2Q
03/31/2023
42.00%
4Q
12/31/2022
42.37%
5Q
09/30/2022
42.54%
6Q
06/30/2022
42.75%
7Q
03/31/2022
42.84%
8Q
12/31/2021
43.00%
9Q
09/30/2021
43.04%
10Q
06/30/2021
43.19%
11Q
03/31/2021
43.42%
12Q
12/31/2020
43.73%
13Q
09/30/2020
44.20%
14Q
06/30/2020
44.27%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BLACK DIAMOND THERAPEUTICS INC
LOADING...